Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1201: Which one of the following statements regarding pre-post clinical trials is most appropriate?

A. They cannot be randomized.
B. They are useful in studies involving mortality.
C. They use the patient as his or her own control. (Correct Answer)
D. They are usually easier to interpret than the comparable parallel clinical trial.

Explanation: ### Explanation **Core Concept: Pre-Post Clinical Trials** A **Pre-Post Study** (also known as a "Before-and-After" study) is a type of quasi-experimental design where measurements are taken from the same group of participants both before and after an intervention. The fundamental principle is that **the patient serves as his or her own control** (Option C). By comparing the baseline data to the post-intervention data within the same individual, researchers can minimize the influence of "between-subject" variability (confounding factors like genetics, age, or socioeconomic status). **Analysis of Options:** * **Option A (Incorrect):** While many pre-post studies are non-randomized, they *can* be randomized (e.g., a Crossover Trial is a specialized version of a pre-post design where the order of treatments is randomized). * **Option B (Incorrect):** These studies are poorly suited for mortality. Mortality is a "one-time" terminal event; you cannot measure a patient "after" death and then compare it to their "before" state in a repetitive clinical sense. They are better suited for chronic, stable conditions (e.g., hypertension, asthma). * **Option D (Incorrect):** They are often **harder** to interpret than parallel trials due to the **"Carry-over effect"** (lingering effects of a previous treatment) and the **"Period effect"** (changes in the disease progression over time). **High-Yield NEET-PG Pearls:** * **Crossover Design:** A sophisticated pre-post trial where patients switch treatments. It requires a **"Washout Period"** to eliminate the carry-over effect. * **Advantage:** Requires a **smaller sample size** than parallel trials because the statistical power is higher when using the same subject. * **Disadvantage:** Not suitable for acute diseases or conditions that are cured by the first intervention.

Question 1202: In the Pearl index formula, what does the pregnancy rate per hundred women-years (HWY) represent?

A. Total accidental pregnancies multiplied by 1200, divided by the number of women observed multiplied by the total months of contraceptive use. (Correct Answer)
B. Total months of exposure to unintended pregnancy multiplied by 1200, divided by accidental pregnancies.
C. Total accidental pregnancies multiplied by 100, divided by the number of women multiplied by the total months of exposure to unintended pregnancy.
D. Total accidental pregnancies divided by the total months of exposure to unintended pregnancy.

Explanation: ### Explanation The **Pearl Index** is the standard method used in epidemiology and clinical trials to measure the **failure rate** of a contraceptive method. It expresses the number of unintended pregnancies per 100 woman-years of exposure. **1. Why Option A is Correct:** The formula for the Pearl Index is: $$\text{Pearl Index} = \frac{\text{Total Accidental Pregnancies} \times 1200}{\text{Total Months of Exposure (Contraceptive Use)}}$$ * **1200** is the constant used because 100 woman-years equals 1,200 months (100 women × 12 months). * The denominator represents the cumulative time all women in the study were at risk of pregnancy while using the method. **2. Why Other Options are Incorrect:** * **Option B:** This incorrectly flips the numerator and denominator. This would calculate "months per pregnancy" rather than a rate. * **Option C:** Using 100 as a multiplier would only be correct if the denominator were in **years**, not months. Since the denominator specifies "total months," 1200 must be used. * **Option D:** This is a simple ratio that does not account for the standardized "100 woman-years" metric required for the Pearl Index. **3. High-Yield Clinical Pearls for NEET-PG:** * **Lower is Better:** A lower Pearl Index indicates higher contraceptive efficacy (e.g., Implants have a lower Pearl Index than Condoms). * **Theoretical vs. Typical Use:** The Pearl Index varies based on "perfect use" (method failure) vs. "typical use" (user failure). * **Alternative Metric:** The **Life Table Analysis** is considered superior to the Pearl Index because it calculates failure rates at specific intervals (e.g., at 6 months, 12 months) and accounts for "drop-outs" more accurately. * **Standard Denominator:** Always remember that 1 Woman-Year = 13 menstrual cycles (if calculating by cycles) or 12 months.

Question 1203: Perinatal mortality rate includes which of the following?

A. Stillbirths and deaths within 7 days of birth (Correct Answer)
B. Neonatal deaths within 30 days of birth
C. Abortions and deaths within 7 days of birth
D. Deaths between 7 and 28 days of birth

Explanation: **Explanation:** The **Perinatal Mortality Rate (PMR)** is a key indicator of the quality of antenatal, intranatal, and postnatal care. According to the WHO, it includes late fetal deaths (stillbirths) and early neonatal deaths. 1. **Why Option A is Correct:** The standard definition of PMR includes **stillbirths** (fetal deaths after 28 weeks of gestation) plus **early neonatal deaths** (deaths occurring within the first 7 completed days of life). The denominator for this rate is the total number of births (live births + stillbirths). This period is critical as it reflects complications related to pregnancy and delivery. 2. **Why Other Options are Incorrect:** * **Option B:** Deaths within 30 days refer to the **Neonatal Mortality Rate** (specifically 0–28 days). PMR only focuses on the first week (0–7 days). * **Option C:** **Abortions** (fetal loss before 20–28 weeks) are excluded from PMR calculations. PMR specifically starts from the period of "viability" (28 weeks in many developing countries). * **Option D:** Deaths between 7 and 28 days are classified as **Late Neonatal Deaths**. **High-Yield Clinical Pearls for NEET-PG:** * **Denominator Alert:** Unlike most mortality rates that use "Total Live Births," PMR uses **(Live Births + Stillbirths)** as the denominator. * **Viability Cut-off:** While the WHO ICD-10 uses 22 weeks (500g) for international comparisons, in India, the cut-off for stillbirths in PMR calculation is typically **28 weeks** of gestation. * **Most Common Cause:** The leading cause of perinatal mortality in India is **Low Birth Weight (LBW)** and prematurity, followed by birth asphyxia.

Question 1204: A malarial survey is conducted in 50 villages having a population of 1 lakh. Out of 20,000 slides examined, 500 turned out to be malaria positive. What is the annual parasite incidence?

A. 5 (Correct Answer)
B. 20
C. 0.5
D. 0.4

Explanation: ### **Explanation** **1. Why Option A is Correct:** The **Annual Parasite Incidence (API)** is a key epidemiological indicator used under the National Center for Vector Borne Diseases Control (NCVBDC) to measure the incidence of malaria in a community. It is defined as the number of confirmed malaria cases per 1,000 population per year. The formula for API is: $$\text{API} = \frac{\text{Total number of positive slides (cases)}}{\text{Total Population}} \times 1,000$$ **Calculation:** * Total Population = 1,00,000 (1 lakh) * Total Positive Slides = 500 * $\text{API} = \frac{500}{1,00,000} \times 1,000 = \mathbf{5}$ **2. Why Other Options are Incorrect:** * **Option B (20):** This value is obtained if you calculate the **Slide Positivity Rate (SPR)**, which is $(\text{Positive Slides} / \text{Total Slides Examined}) \times 100$, i.e., $(500 / 20,000) \times 100 = 2.5\%$. If one mistakenly uses 1,000 as a multiplier for SPR, they get 25, which is close to 20 but mathematically irrelevant here. * **Option C (0.5):** This represents the percentage of the population infected (500/1,00,000 × 100), not the API. * **Option D (0.4):** This is the result of dividing positive slides by the total slides examined (500/20,000 = 0.025), which does not correspond to the API formula. **3. High-Yield Clinical Pearls for NEET-PG:** * **Annual Blood Examination Rate (ABER):** Measures the efficiency of the surveillance system. Formula: $(\text{Slides Examined} / \text{Total Population}) \times 100$. In this case, ABER is 20% (Target is usually >10%). * **Slide Falciparum Rate (SFR):** $(\text{Total P. falciparum positive slides} / \text{Total slides examined}) \times 100$. * **API Threshold:** An API of **<2** is the criterion used in India to shift from the "control" phase to the "pre-elimination" phase in specific districts.

Question 1205: Primordial prevention is aimed at which group of individuals?

A. Individuals without any risk factors (Correct Answer)
B. Individuals with established risk factors
C. Individuals diagnosed with a disease
D. Individuals experiencing complications of a disease

Explanation: **Explanation:** **Primordial prevention** is a unique concept in epidemiology that focuses on preventing the **emergence or development of risk factors** in countries or population groups where they have not yet appeared. It targets the entire population, specifically **individuals without any risk factors**, by discouraging the adoption of harmful lifestyles (e.g., preventing children from starting smoking or promoting healthy eating habits to prevent obesity). **Analysis of Options:** * **Option A (Correct):** Primordial prevention acts before the risk factor exists. It aims at the social, economic, and environmental determinants of health to ensure risk factors do not take root. * **Option B (Incorrect):** This refers to **Primary Prevention**. Here, the risk factor is already present (e.g., a smoker or a person with hypertension), and the goal is to prevent the onset of disease through specific protection (vaccines) or health promotion. * **Option C (Incorrect):** This refers to **Secondary Prevention**. The disease has already started (early pathogenesis), and the goal is early diagnosis and prompt treatment to arrest the disease progress. * **Option D (Incorrect):** This refers to **Tertiary Prevention**. The disease has advanced to a late stage, and the goal is disability limitation and rehabilitation. **High-Yield NEET-PG Pearls:** * **Key Phrase:** "Prevention of the emergence of risk factors." * **Target Group:** Primarily children and adolescents (where habits are formed). * **Mode of Intervention:** Individual and mass education. * **Classic Example:** National policies promoting physical activity to prevent the future rise of Coronary Heart Disease (CHD) in a developing nation.

Question 1206: A disease that is widespread throughout the world is known as:

A. Endemic
B. Epidemic
C. Pandemic (Correct Answer)
D. Sporadic

Explanation: ### Explanation The correct answer is **C. Pandemic**. **Understanding the Concept:** A **Pandemic** is defined as an epidemic that has spread over several countries or continents, usually affecting a large number of people. The key differentiator is the **geographic scale**. While an epidemic is localized to a specific region or population, a pandemic implies a global distribution (e.g., COVID-19, H1N1 Influenza). **Analysis of Incorrect Options:** * **A. Endemic:** Refers to the constant presence of a disease or infectious agent within a given geographic area or population group without external input (e.g., Malaria in certain parts of India). It represents the "usual" prevalence. * **B. Epidemic:** The occurrence of cases of an illness in a community or region clearly in excess of normal expectancy. It is localized and originates from a common source or spread. * **D. Sporadic:** Cases that occur irregularly, haphazardly, and infrequently. The cases are so few and separated in space and time that there is no evidence of a common source (e.g., Tetanus, Polio in certain regions). **NEET-PG High-Yield Pearls:** * **Prosodemic:** Another term for a "propagated epidemic" (person-to-person spread). * **Epizootic:** An epidemic occurring in an animal population (e.g., Anthrax, Rabies). * **Enzootic:** An endemic disease among animals. * **Epornitic:** An epidemic occurring in a bird population. * **Exotic:** A disease that is not native to a country but is introduced from outside (e.g., Lassa fever in India).

Question 1207: What does PQLI stand for?

A. IMR, Life expectancy, literacy
B. MMR, Life expectancy, literacy
C. MMR, IMR, Life expectancy
D. Physical Quality of Life Index (IMR, Life expectancy, literacy) (Correct Answer)

Explanation: **Explanation:** The **Physical Quality of Life Index (PQLI)** is a composite indicator developed by Morris David Morris to measure the quality of life or social well-being of a country. Unlike the Human Development Index (HDI), which includes economic factors (GNI), the PQLI focuses purely on social and health outcomes. **Why Option D is Correct:** The PQLI is calculated using three specific indicators, each measured on a scale of 0 to 100: 1. **Infant Mortality Rate (IMR):** Reflects the health status and nutritional level of the population. 2. **Life Expectancy at Age 1:** Note that it is specifically at age 1, not at birth (to avoid double-counting IMR). 3. **Basic Literacy Rate:** Reflects the educational status of the population. **Analysis of Incorrect Options:** * **Options B & C:** These include **MMR (Maternal Mortality Ratio)**. While MMR is a vital health indicator, it is not a component of the PQLI. * **Option A:** While it lists the correct components, it fails to define the acronym "PQLI" as the Physical Quality of Life Index, making Option D the most comprehensive and accurate choice. **High-Yield Clinical Pearls for NEET-PG:** * **Range:** PQLI scores range from **0 (worst) to 100 (best)**. * **PQLI vs. HDI:** PQLI includes **IMR, Life Expectancy at Age 1, and Literacy**. HDI includes **Life Expectancy at Birth, Mean/Expected Years of Schooling, and GNI per capita**. * **Key Distinction:** PQLI does **not** include per capita income (economic growth), making it a better measure of social equity. * **India's Context:** Historically, PQLI was used to show that countries with low GDP could still achieve high social development (e.g., Kerala).

Question 1208: Congenital immunity is NOT found in which of the following diseases?

A. Pertussis (Correct Answer)
B. Mumps
C. Rubella
D. Measles

Explanation: **Explanation:** The concept of **congenital immunity** (passive natural immunity) refers to the transfer of maternal antibodies (IgG) across the placenta to the fetus. This provides the newborn with temporary protection against specific infections during the first few months of life. **Why Pertussis is the Correct Answer:** Pertussis (Whooping Cough) is the notable exception to this rule. Even if a mother has high titers of antibodies due to past infection or vaccination, **maternal antibodies against *Bordetella pertussis* are not transferred in sufficient quantities** to provide effective protection to the neonate. Consequently, infants are highly susceptible to pertussis from birth, which is why the disease carries high morbidity and mortality in this age group. This is also the clinical rationale for vaccinating pregnant women with Tdap (to boost specific antibody transfer) and starting the primary DPT series as early as 6 weeks. **Why the Other Options are Incorrect:** * **Measles, Mumps, and Rubella:** These are viral infections where maternal IgG antibodies are efficiently transferred across the placenta. This congenital immunity typically protects the infant for approximately 6 to 9 months. This is why the Measles/MR vaccine is generally not administered before 9 months of age, as the persisting maternal antibodies would neutralize the live vaccine virus, rendering it ineffective. **High-Yield Clinical Pearls for NEET-PG:** * **Passive Immunity:** Only IgG crosses the placenta; IgA is transferred via colostrum/breast milk. * **Vaccination Timing:** The presence of congenital immunity dictates the "minimum age" for many live vaccines (e.g., Measles at 9 months). * **Pertussis Prevention:** Because there is no natural congenital immunity, the WHO recommends the "cocooning strategy" (vaccinating all close contacts) and maternal immunization during pregnancy to protect the newborn.

Question 1209: Which study design is most appropriate for studying the natural history of a disease?

A. Cross-sectional study
B. Ecological study
C. Cohort study (Correct Answer)
D. Randomized controlled trial

Explanation: **Explanation:** The **Cohort study** is the most appropriate design for studying the **natural history of a disease** because it is a longitudinal, prospective study that follows a group of individuals from a state of health (exposure) to the development of an outcome. By observing participants over time, researchers can document the entire progression of a disease—from its subclinical onset to recovery, chronicity, or death—and calculate the **Incidence** and **Relative Risk**. **Why other options are incorrect:** * **Cross-sectional study:** This is a "snapshot" study that measures prevalence at a single point in time. It cannot establish a temporal relationship or track disease progression. * **Ecological study:** This uses populations or groups as the unit of study rather than individuals. It is used for generating hypotheses but cannot track individual disease history. * **Randomized Controlled Trial (RCT):** This is an experimental study designed to test the efficacy of an intervention (like a drug). It is not used to observe the "natural" course of a disease because the researcher actively intervenes. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence** can only be calculated from Cohort studies. * **Prevalence** is calculated from Cross-sectional studies. * **Odds Ratio** is the key measure of association in Case-control studies. * **Temporal Association:** Cohort studies are the best observational design to establish that the "cause" preceded the "effect."

Question 1210: What do migration studies explain?

A. Distribution of disease
B. Genetic factors affecting disease (Correct Answer)
C. Social status of immigrants
D. None of the above

Explanation: **Explanation:** Migration studies are a powerful epidemiological tool used to distinguish the relative contributions of **environmental (extrinsic)** factors versus **genetic (intrinsic)** factors in the etiology of a disease. **1. Why the correct answer is right:** When a population moves from a low-risk area to a high-risk area (or vice versa), researchers observe changes in their disease patterns. * If the disease frequency in the migrants remains similar to their **country of origin**, it suggests a strong **genetic basis** (Option B). * If the disease frequency changes to match the **host country**, it suggests that **environmental or lifestyle factors** are the primary drivers. By comparing these groups, migration studies help isolate whether a disease is primarily "nature" (genetics) or "nurture" (environment). **2. Why other options are wrong:** * **Option A (Distribution of disease):** While migration affects distribution, the *primary purpose* of a migration "study" as a research design is to test etiological hypotheses regarding genetics vs. environment, not merely to map where cases are. * **Option C (Social status):** While sociologists may study this, in medical epidemiology, migration studies focus on disease causation and risk factors rather than the socioeconomic integration of immigrants. **High-Yield Facts for NEET-PG:** * **Classic Example:** Japanese migrants to the USA. They showed a decrease in stomach cancer rates (common in Japan) and an increase in colon cancer rates (common in the USA), proving that these cancers are heavily influenced by environmental/dietary factors rather than just genetics. * **Twin Studies vs. Migration Studies:** Both are used to study the Gene-Environment interaction. Twin studies focus more on heritability, while migration studies focus on the impact of a changing environment on a stable gene pool.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free